重症监护病房患者血流感染预后危险因素分析
该回顾性研究纳入贵州医科大学附属医院ICU 2019年1月1日至9月30日血培养阳性的血流感染患者154例,检出156株细菌,以凝固酶阴性葡萄球菌(35.9%)为主,革兰阳性菌75株、革兰阴性菌70株、真菌11株。按28天预后分为生存组81例和死亡组73例,死亡组男性比例、APACHE II评分、合并糖尿病和肿瘤比例、血流感染后CRRT和输血比例、连续使用血管活性药物≥72小时比例均与生存组有显著差异。Logistic回归显示APACHE II评分(OR=1.279,95%CI 1.158~1.412,P<0.001)和血流感染后CRRT(OR=3.522,95%CI 1.013~12.245,P=0.048)是独立危险因素,平均动脉压为保护因素(OR=0.961,95%CI 0.927~0.996,P=0.031)。
要点
- 154例ICU血流感染患者中,检出156株细菌:革兰阳性菌75株、革兰阴性菌70株、真菌11株,革兰阳性菌仍占主导。
- 死亡组APACHE II评分高于生存组(27.1±7.0 vs. 19.5±6.7,P<0.05),是预后独立危险因素(OR=1.279,95%CI 1.158~1.412,P<0.001)。
- 死亡组血流感染后行CRRT比例高于生存组(39.7% vs. 16.0%,P<0.05),CRRT是独立危险因素(OR=3.522,95%CI 1.013~12.245,P=0.048)。
- 平均动脉压是预后保护因素(OR=0.961,95%CI 0.927~0.996,P=0.031),死亡组血流感染后前3天平均动脉压低于生存组(72.8±13.6 mmHg vs. 79.7±12.9 mmHg,P<0.05)。
- 死亡组血小板计数低于生存组(124.93±98.21×10⁹/L vs. 181.15±116.39×10⁹/L,P<0.05),天冬氨酸氨基转移酶高于生存组[75.40(38.50, 140.95)U/L vs. 56.20(29.20, 85.70)U/L,P<0.05]。
适用人群与场景
- 贵州医科大学附属医院ICU 2019年1月1日至9月30日血培养阳性的血流感染患者,共154例。
研究设计与关键结果
- 回顾性研究,纳入ICU血流感染患者154例,检出156株细菌:革兰阳性菌75株、革兰阴性菌70株、真菌11株;前五位病原体为凝固酶阴性葡萄球菌(35.9%)、肺炎克雷伯菌(12.8%)、鲍曼不动杆菌(9.0%)、肠球菌(9.0%)、大肠埃希菌(8.3%)。
- 革兰阳性菌中多重耐药菌45株(60.0%),革兰阴性菌中多重耐药菌40株(57.1%),真菌中多重耐药菌1株(9.1%)。
- 按28天预后分为生存组81例和死亡组73例;两组年龄、ICU住院时间、血流感染后机械通气时间、合并慢性阻塞性肺疾病、高血压、心血管疾病或慢性肾功能不全比例均无显著差异(均P>0.05)。
- 死亡组男性比例低于生存组[58.9%(43/73)vs. 75.3%(61/81),P<0.05],APACHE II评分高于生存组(27.1±7.0 vs. 19.5±6.7,P<0.05)。
- 死亡组血流感染后前3天平均动脉压低于生存组[72.8±13.6 mmHg vs. 79.7±12.9 mmHg,P<0.05;1 mmHg=0.133 kPa]。
- 死亡组合并糖尿病[28.8%(29/73)vs. 12.3%(10/81)]、肿瘤[19.2%(14/73)vs. 7.4%(6/81)]、血流感染后CRRT[39.7%(29/73)vs. 16.0%(13/81)]、输血[64.4%(47/73)vs. 46.9%(38/81)]及连续使用血管活性药物≥72小时[37.0%(27/73)vs. 12.3%(10/81)]比例均高于生存组(均P<0.05)。
- 死亡组血小板计数低于生存组[124.93±98.21×10⁹/L vs. 181.15±116.39×10⁹/L,P<0.05],天冬氨酸氨基转移酶高于生存组[75.40(38.50, 140.95)U/L vs. 56.20(29.20, 85.70)U/L,P<0.05],其余实验室指标两组差异无统计学意义(均P>0.05)。
- Logistic回归分析显示,APACHE II评分(OR=1.279,95%CI 1.158~1.412,P<0.001)和血流感染后CRRT(OR=3.522,95%CI 1.013~12.245,P=0.048)是影响预后的独立危险因素,平均动脉压为保护因素(OR=0.961,95%CI 0.927~0.996,P=0.031)。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU血流感染以革兰阳性菌为主、革兰阴性菌次之,APACHE II评分和血流感染后CRRT是独立预后危险因素。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the prognostic risk factors of bloodstream infection (BSI) in intensive care unit (ICU) patients, furthermore, to provide a reliable evidence for early warning and treatment for the critical patients with BSI.
METHODS: A retrospective study was performed. The clinical data of patients with blood culture-positive admitted to ICU of the Affiliated Hospital of Guizhou Medical University from January 1 to September 30, 2019 were analyzed. The data including gender, age, proportion of basic diseases, acute physiology and chronic health evaluation II (APACHE II), the duration of mechanical ventilation after being diagnosed with BSI, length of stay in ICU, aggressive operation and blood product infusion after BSI, proportion of using continuous renal replacement therapy (CRRT) and continuous vasoactive agents for more than 72 hours after being diagnosed with BSI, and site of central venous catheterization were recorded. Meantime, the worst laboratory values within 72 hours after being diagnosed with BSI, information about pathogenic microorganism categories and distributions were collected and analyzed. The patients were divided into survival and death groups based on the the 28-day prognosis, and the differences of clinical data between the two groups were compared. Logistic regression analysis was used to select the independent prognostic risk factors of BSI.
RESULTS: One hundred and fifty-four patients with positive results of BSI were enrolled, and the 156 strains of bacteria were detected, including 75 Gram positive (G+) bacteria strains, 70 Gram negative (G-) bacteria strains and 11 fungi strains among those BSI patients. The top five pathogenic microorganisms were Coagulase negative staphylococcus (35.9%), Klebsiella pneumonia (12.8%), Acinetobacter baumannii (9.0%), Enterococci (9.0%), and Escherichia coli (8.3%). There were 45 strains (60.0%) of multidrug-resistant strains in G+ bacteria and 40 strains of multidrug-resistant strains (57.1%) in G- bacterial strains, but in fungi there was only 1 strain (9.1%). There were 81 cases in survival group and 73 cases in death group according to 28-day prognosis. We found that there were no significant differences between the comparators in age, lenth of stay in ICU, duration for mechanical ventilation after being diagnosed with BSI, percentage of BSI with chronic obstructive pulmonary disease (COPD), hypertension, cardiovascular disease or chronic kidney dysfunction (all P > 0.05). In death group, the proportion of male was obviously lower than that of survival group [58.9% (43/73) vs. 75.3% (61/81), P < 0.05] and APACHE II score was significantly higher than that in survival group (27.1±7.0 vs. 19.5±6.7, P < 0.05). The mean arterial pressure (MAP) of death group on first 3 days of BSI was significantly lower than that of survival group [mmHg (1 mmHg = 0.133 kPa): 72.8±13.6 vs. 79.7±12.9, P < 0.05), in the death group, the proportion of patients complicated with diabetes, cancer [28.8% (29/73) vs. 12.3% (10/81), 19.2% (14/73) vs. 7.4% (6/81)], post-BSI CRRT and blood transfusion [39.7% (29/73) vs. 16.0% (13/81), 64.4% (47/73) vs. 46.9% (38/81)], and continuous use of asoactie drugs for ≥ 72 hours [37.0% (27/73) vs. 12.3% (10/81)] were significantly higher than those in the survival group (all P < 0.05). In death group, platelet count (PLT) was significantly decreased than that of survival group [×109/L: 124.93±98.21 vs. 181.15±116.39,P < 0.05], aspartate aminotransferase (AST) level was significantly higher than that of survival group [U/L: 75.40 (38.50, 140.95) vs. 56.20 (29.20, 85.70), P < 0.05], the rest of the laboratory indexes had no statistically significant differences between the two groups (all P > 0.05). The results of Logistic regression analysis showed that the APACHE II score [odds ratio (OR) = 1.279, 95% confidence interval (95%CI) was 1.158 to 1.412, P < 0.001], CRRT after BSI (OR = 3.522, 95%CI was 1.013 to 12.245, P = 0.048) were independent risk factors affecting the prognosis of patients with BSI, and MAP is a protective factor for prognosis (OR = 0.961, 95%CI was 0.927 to 0.996, P = 0.031).
CONCLUSIONS: In our ICU, G+ bacteria are still dominant in bloodstream infection, G- bacteria take the second place. Besides, APACHE II score and CRRT after being diagnosed with BSI are the independent prognostic risk factors.
参考来源
- Huang Y, Gong C, Fu J, et al. [Analysis of prognostic risk factors of bloodstream infection in intensive care unit patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33541494. doi:10.3760/cma.j.cn121430-20201016-00675
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。